During the past decade, Odesa Regional Clinical Hospital conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 32 clinical trials were completed, i.e. on average, 50.8% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 27 clinical trials were completed. i.e. 108% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Odesa Regional Clinical Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 12 trials, followed by "Eli Lilly and Company" with 9 trials sponsored, "Celgene" with 7 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored and "Galapagos NV" with 7 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Odesa Regional Clinical Hospital" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Academic Medical Organization of Southwestern Ontario" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Bausch Health Americas, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Odesa Regional Clinical Hospital" are "Ulcerative Colitis" (14 trials), "Crohn's Disease" (10 trials), "Colitis, Ulcerative" (7 trials), "Crohn Disease" (7 trials) and "Arthritis, Psoriatic" (4 trials). Many other conditions were trialed in "Odesa Regional Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Odesa Regional Clinical Hospital" are "Drug" (71 trials), "Other" (8 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (42 trials), "Guselkumab" (6 trials), "Filgotinib" (5 trials), "Mirikizumab" (5 trials) and "Etrasimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Odesa Regional Clinical Hospital" are 68 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Odesa Regional Clinical Hospital". undefined are not yet recruiting, 14 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in Odesa Regional Clinical Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Odesa Regional Clinical Hospital, 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".

Odesa Regional Clinical Hospital has several departments that took part in Clinical trials: "Communal Institution "Odessa Regional Clinical Psych Hospital #1" Department of Day Care" - 2 trials